Three-in-One Injectable Hydrogel Orchestrating Host-Bacteria Targeting, Retention, and Autophagy for Methicillin-Resistant Staphylococcus aureus-Infected Mastitis Therapy.

Authors

Xuelian Fan, Yongyue Li, Xiaolong Xu, Yongfeng Yu, Qingmeng Li, Junhua Han, Chun Zhang, Tong Zhou, Jianzhong Shen, Xiaowei Ma

Published in

ACS nano. Volume 20. Issue 44. Pages 29765-29784. Nov 10, 2026.

Abstract

MRSA mastitis is clinically refractory and characterized by progressive inflammation driven by intracellular bacteria that form persistent niches in mammary epithelial cells and macrophages to evade antimicrobial clearance. Conventional antibiotics, particularly β-lactams, are widely used but suffer from poor intracellular accumulation, failing to reach these reservoirs. Even nanocarrier-based strategies struggle to achieve efficient endosomal escape and precise intracellular targeting. Herein, we report a fibronectin-functionalized, fluorinated PLGA nanoparticle encapsulating amoxicillin and sulbactam (Fn-F-PLGA@A/S) engineered with a 2.5% (w/w) fluorinated core for efficient endosomal escape. The fibronectin decoration enables sequential targeting of both host integrins and bacterial fibronectin-binding proteins (FnBPs). Fn-F-PLGA@A/S achieved efficient intracellular delivery, clearing 90% of intracellular MRSA in macrophages and epithelial cells within 4 h in vitro. To prolong mammary retention, Fn-F-PLGA@A/S was loaded into a thermosensitive hydrogel. In a murine MRSA mastitis model, a single intramammary dose of the gel formulation achieved >90% bacterial reduction, attenuated TNF-α and IL-6, and preserved alveolar architecture and tight junctions. Proteomic analysis revealed upregulation of AMPK-mediated autophagy, suggesting that beyond direct antibiotic action, the potent intracellular clearance achieved by Fn-F-PLGA may involve the engagement of host autophagic machinery, potentially facilitating the sequestration of MRSA within degradative compartments. Collectively, by integrating sequential targeting, sustained local retention, and autophagic engagement, this platform provides a robust strategy to address the key limitations of conventional antibiotics against intracellular pathogens in refractory infections.

PMID:
43007749
Bibliographic data and abstract were imported from PubMed on 11 Nov 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.